{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:14:19Z","timestamp":1789586059450,"version":"build-2803163510"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004507","name":"CSIR-CDRI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00415-025-13429-x","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:20:30Z","timestamp":1770787230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unraveling the core: hub genes bridging familial and sporadic Parkinson\u2019s disease"],"prefix":"10.1007","volume":"273","author":[{"given":"Simran","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulshan","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baisakhi","family":"Moharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-7792","authenticated-orcid":false,"given":"Sonia","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"13429_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener 6:28. https:\/\/doi.org\/10.1186\/s40035-017-0099-z","journal-title":"Transl Neurodegener"},{"key":"13429_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1503\/cmaj.151179","volume":"188","author":"P Rizek","year":"2016","unstructured":"Rizek P, Kumar N, Jog MS (2016) An update on the diagnosis and treatment of Parkinson disease. CMAJ 188:1157\u20131165. https:\/\/doi.org\/10.1503\/cmaj.151179","journal-title":"CMAJ"},{"key":"13429_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00109-013-1038-9","volume":"91","author":"SE Eisbach","year":"2013","unstructured":"Eisbach SE, Outeiro TF (2013) Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson\u2019s disease pathology. J Mol Med (Berl) 91:693\u2013703. https:\/\/doi.org\/10.1007\/s00109-013-1038-9","journal-title":"J Mol Med (Berl)"},{"key":"13429_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1720621","volume":"2016","author":"L Xu","year":"2016","unstructured":"Xu L, Pu J (2016) Alpha-synuclein in Parkinson\u2019s disease: from pathogenetic dysfunction to potential clinical application. Parkinsons Dis 2016:1720621. https:\/\/doi.org\/10.1155\/2016\/1720621","journal-title":"Parkinsons Dis"},{"key":"13429_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3389\/fnmol.2018.00391","volume":"11","author":"Y Zhang","year":"2018","unstructured":"Zhang Y et al (2018) A comprehensive analysis of the association between SNCA polymorphisms and the risk of Parkinson\u2019s disease. Front Mol Neurosci 11:391. https:\/\/doi.org\/10.3389\/fnmol.2018.00391","journal-title":"Front Mol Neurosci"},{"key":"13429_CR6","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.259724","author":"C Zhu","year":"2023","unstructured":"Zhu C, Herbst S, Lewis PA (2023) Leucine-rich repeat kinase 2 at a glance. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.259724","journal-title":"J Cell Sci"},{"key":"13429_CR7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/1535370215579162","volume":"240","author":"JW Lee","year":"2015","unstructured":"Lee JW, Cannon JR (2015) LRRK2 mutations and neurotoxicant susceptibility. Exp Biol Med (Maywood) 240:752\u2013759. https:\/\/doi.org\/10.1177\/1535370215579162","journal-title":"Exp Biol Med (Maywood)"},{"key":"13429_CR8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BST20180462","volume":"47","author":"JH Kluss","year":"2019","unstructured":"Kluss JH, Mamais A, Cookson MR (2019) LRRK2 links genetic and sporadic Parkinson\u2019s disease. Biochem Soc Trans 47:651\u2013661. https:\/\/doi.org\/10.1042\/BST20180462","journal-title":"Biochem Soc Trans"},{"key":"13429_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron 85:257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"key":"13429_CR10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/humu.22808","volume":"36","author":"FC Fiesel","year":"2015","unstructured":"Fiesel FC et al (2015) Structural and functional impact of Parkinson disease-associated mutations in the E3 ubiquitin ligase Parkin. Hum Mutat 36:774\u2013786. https:\/\/doi.org\/10.1002\/humu.22808","journal-title":"Hum Mutat"},{"key":"13429_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014228","volume":"98","author":"YQ Fang","year":"2019","unstructured":"Fang YQ, Mao F, Zhu MJ, Li XH (2019) Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: a case report. Medicine (Baltimore) 98:e14228. https:\/\/doi.org\/10.1097\/MD.0000000000014228","journal-title":"Medicine (Baltimore)"},{"key":"13429_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","volume":"51","author":"LP Dolgacheva","year":"2019","unstructured":"Dolgacheva LP, Berezhnov AV, Fedotova EI, Zinchenko VP, Abramov AY (2019) Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease. J Bioenerg Biomembr 51:175\u2013188. https:\/\/doi.org\/10.1007\/s10863-019-09798-4","journal-title":"J Bioenerg Biomembr"},{"key":"13429_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cells13040296","author":"LD Skou","year":"2024","unstructured":"Skou LD, Johansen SK, Okarmus J, Meyer M (2024) Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/cells13040296","journal-title":"Cells"},{"key":"13429_CR14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.parkreldis.2014.08.019","volume":"20","author":"J Siuda","year":"2014","unstructured":"Siuda J et al (2014) Early-onset Parkinson\u2019s disease due to PINK1 p. Q456X mutation\u2013clinical and functional study. Parkinsonism Relat Disord 20:1274\u20131278. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.08.019","journal-title":"Parkinsonism Relat Disord"},{"key":"13429_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12031-013-0207-1","volume":"53","author":"W Yunfu","year":"2014","unstructured":"Yunfu W et al (2014) PINK1 and its familial Parkinson\u2019s disease-associated mutation regulate brain vascular endothelial inflammation. J Mol Neurosci 53:109\u2013116. https:\/\/doi.org\/10.1007\/s12031-013-0207-1","journal-title":"J Mol Neurosci"},{"key":"13429_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242317027","volume":"24","author":"CJ Choong","year":"2023","unstructured":"Choong CJ, Mochizuki H (2023) Involvement of mitochondria in Parkinson\u2019s disease. Int J Mol Sci 24:doi:10.3390\/ijms242317027","journal-title":"Int J Mol Sci"},{"key":"13429_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081261","author":"L Smith","year":"2022","unstructured":"Smith L, Schapira AHV (2022) GBA variants and parkinson disease: mechanisms and treatments. Cells. https:\/\/doi.org\/10.3390\/cells11081261","journal-title":"Cells"},{"key":"13429_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fnagi.2020.00097","volume":"12","author":"M Avenali","year":"2020","unstructured":"Avenali M, Blandini F, Cerri S (2020) Glucocerebrosidase defects as a major risk factor for Parkinson\u2019s disease. Front Aging Neurosci 12:97. https:\/\/doi.org\/10.3389\/fnagi.2020.00097","journal-title":"Front Aging Neurosci"},{"key":"13429_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2024.103981","author":"P Padhan","year":"2024","unstructured":"Padhan P, Kumar NS, Verma S (2024) Glutathione S-transferase: a keystone in Parkinson\u2019s disease pathogenesis and therapy. Mol Cell Neurosci. https:\/\/doi.org\/10.1016\/j.mcn.2024.103981","journal-title":"Mol Cell Neurosci"},{"key":"13429_CR20","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1212\/WNL.0000000000200699","volume":"99","author":"S Grover","year":"2022","unstructured":"Grover S et al (2022) Genome-wide association and meta-analysis of age at onset in Parkinson disease: evidence from the COURAGE-PD consortium. Neurology 99:e698\u2013e710. https:\/\/doi.org\/10.1212\/WNL.0000000000200699","journal-title":"Neurology"},{"key":"13429_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10571-018-0587-4","volume":"38","author":"A Karimi-Moghadam","year":"2018","unstructured":"Karimi-Moghadam A, Charsouei S, Bell B, Jabalameli MR (2018) Parkinson disease from Mendelian forms to genetic susceptibility: new molecular insights into the neurodegeneration process. Cell Mol Neurobiol 38:1153\u20131178. https:\/\/doi.org\/10.1007\/s10571-018-0587-4","journal-title":"Cell Mol Neurobiol"},{"key":"13429_CR22","doi-asserted-by":"publisher","first-page":"31167","DOI":"10.1038\/s41598-024-82470-z","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z et al (2024) Multi-omics analysis reveals the genetic aging landscape of Parkinson\u2019s disease. Sci Rep 14:31167. https:\/\/doi.org\/10.1038\/s41598-024-82470-z","journal-title":"Sci Rep"},{"key":"13429_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s40001-024-02201-y","volume":"29","author":"L Ma","year":"2024","unstructured":"Ma L et al (2024) Integrating bioinformatics and machine learning to uncover lncRNA LINC00269 as a key regulator in Parkinson\u2019s disease via pyroptosis pathways. Eur J Med Res 29:582. https:\/\/doi.org\/10.1186\/s40001-024-02201-y","journal-title":"Eur J Med Res"},{"key":"13429_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2425064","volume":"56","author":"J Lin","year":"2024","unstructured":"Lin J et al (2024) Identification of copper metabolism-related markers in Parkinson\u2019s disease. Ann Med 56:2425064. https:\/\/doi.org\/10.1080\/07853890.2024.2425064","journal-title":"Ann Med"},{"key":"13429_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.slast.2024.100212","volume":"29","author":"H Cheng","year":"2024","unstructured":"Cheng H et al (2024) Deciphering the role of heat shock protein HSPA1L: biomarker discovery and prognostic insights in Parkinson\u2019s disease and glioma. SLAS Technol 29:100212. https:\/\/doi.org\/10.1016\/j.slast.2024.100212","journal-title":"SLAS Technol"},{"key":"13429_CR26","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.2147\/IJGM.S486214","volume":"17","author":"H Peng","year":"2024","unstructured":"Peng H, Cheng Y, Chen Q, Qin L (2024) Integrated transcriptomic and machine learning analysis identifies EAF2 as a diagnostic biomarker and key pathogenic factor in Parkinson\u2019s disease. Int J Gen Med 17:5547\u20135562. https:\/\/doi.org\/10.2147\/IJGM.S486214","journal-title":"Int J Gen Med"},{"key":"13429_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41531-024-00839-3","volume":"10","author":"A Beric","year":"2024","unstructured":"Beric A et al (2024) Circulating blood circular RNA in Parkinson\u2019s disease; from involvement in pathology to diagnostic tools in at-risk individuals. NPJ Parkinsons Dis 10:222. https:\/\/doi.org\/10.1038\/s41531-024-00839-3","journal-title":"NPJ Parkinsons Dis"},{"key":"13429_CR28","doi-asserted-by":"publisher","first-page":"25763","DOI":"10.1038\/s41598-024-77401-x","volume":"14","author":"Q Lyu","year":"2024","unstructured":"Lyu Q, Chen R, Qiu Z, Wang C, Liu R (2024) Druggable targets for Parkinson\u2019s disease: transcriptomics based Mendelian randomization study. Sci Rep 14:25763. https:\/\/doi.org\/10.1038\/s41598-024-77401-x","journal-title":"Sci Rep"},{"key":"13429_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s12031-024-02272-w","volume":"74","author":"X Wang","year":"2024","unstructured":"Wang X, Yang G, Lai Y, Li Y, Liu X (2024) Exploring the hub genes and potential mechanisms of complement system-related genes in Parkinson disease: based on transcriptome sequencing and Mendelian randomization. J Mol Neurosci 74:95. https:\/\/doi.org\/10.1007\/s12031-024-02272-w","journal-title":"J Mol Neurosci"},{"key":"13429_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12883-016-0784-z","volume":"17","author":"A Planken","year":"2017","unstructured":"Planken A et al (2017) Looking beyond the brain to improve the pathogenic understanding of Parkinson\u2019s disease: implications of whole transcriptome profiling of patients\u2019 skin. BMC Neurol 17:6. https:\/\/doi.org\/10.1186\/s12883-016-0784-z","journal-title":"BMC Neurol"},{"key":"13429_CR31","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41597-024-03909-6","volume":"11","author":"Z Yu","year":"2024","unstructured":"Yu Z et al (2024) Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson\u2019s disease patients. Sci Data 11:1128. https:\/\/doi.org\/10.1038\/s41597-024-03909-6","journal-title":"Sci Data"},{"key":"13429_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1997","volume":"16","author":"B Zhu","year":"2024","unstructured":"Zhu B et al (2024) Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains. Sci Transl Med 16:eabo1997. https:\/\/doi.org\/10.1126\/scitranslmed.abo1997","journal-title":"Sci Transl Med"},{"key":"13429_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath T et al (2022) Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat Neurosci 25:588\u2013595. https:\/\/doi.org\/10.1038\/s41593-022-01061-1","journal-title":"Nat Neurosci"},{"key":"13429_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2022.107958","volume":"41","author":"E Novosadova","year":"2022","unstructured":"Novosadova E et al (2022) Transcriptome datasets of neural progenitors and neurons differentiated from induced pluripotent stem cells of healthy donors and Parkinson\u2019s disease patients with mutations in the PARK2 gene. Data Brief 41:107958. https:\/\/doi.org\/10.1016\/j.dib.2022.107958","journal-title":"Data Brief"},{"key":"13429_CR35","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s10571-021-01146-8","volume":"42","author":"A Zaccaria","year":"2022","unstructured":"Zaccaria A et al (2022) Multiomic analyses of dopaminergic neurons isolated from human Substantia nigra in Parkinson\u2019s disease: a descriptive and exploratory study. Cell Mol Neurobiol 42:2805\u20132818. https:\/\/doi.org\/10.1007\/s10571-021-01146-8","journal-title":"Cell Mol Neurobiol"},{"key":"13429_CR36","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.15252\/emmm.201505439","volume":"7","author":"R Fernandez-Santiago","year":"2015","unstructured":"Fernandez-Santiago R et al (2015) Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson\u2019s disease patients. EMBO Mol Med 7:1529\u20131546. https:\/\/doi.org\/10.15252\/emmm.201505439","journal-title":"EMBO Mol Med"},{"key":"13429_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.699562","volume":"14","author":"J Aguila","year":"2021","unstructured":"Aguila J et al (2021) Spatial RNA sequencing identifies robust markers of vulnerable and resistant human midbrain dopamine neurons and their expression in Parkinson\u2019s disease. Front Mol Neurosci 14:699562. https:\/\/doi.org\/10.3389\/fnmol.2021.699562","journal-title":"Front Mol Neurosci"},{"key":"13429_CR38","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.stemcr.2022.08.010","volume":"17","author":"J Drouin-Ouellet","year":"2022","unstructured":"Drouin-Ouellet J et al (2022) Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson\u2019s disease. Stem Cell Reports 17:2203\u20132219. https:\/\/doi.org\/10.1016\/j.stemcr.2022.08.010","journal-title":"Stem Cell Reports"},{"key":"13429_CR39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.stem.2020.08.002","volume":"27","author":"JW Kim","year":"2020","unstructured":"Kim JW et al (2020) Defects in mRNA translation in LRRK2-mutant hiPSC-derived dopaminergic neurons lead to dysregulated calcium homeostasis. Cell Stem Cell 27:633-645 e637. https:\/\/doi.org\/10.1016\/j.stem.2020.08.002","journal-title":"Cell Stem Cell"},{"key":"13429_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109088","author":"E Khan","year":"2023","unstructured":"Khan E, Hasan I, Haque ME (2023) Parkinson\u2019s disease: exploring different animal model systems. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24109088","journal-title":"Int J Mol Sci"},{"key":"13429_CR41","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1101\/gr.10.5.703","volume":"10","author":"CH Lai","year":"2000","unstructured":"Lai CH, Chou CY, Ch\u2019ang LY, Liu CS, Lin W (2000) Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res 10:703\u2013713. https:\/\/doi.org\/10.1101\/gr.10.5.703","journal-title":"Genome Res"},{"key":"13429_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9040073","author":"AL Gaeta","year":"2019","unstructured":"Gaeta AL, Caldwell KA, Caldwell GA (2019) Found in translation: the utility of C. elegans alpha-synuclein models of Parkinson\u2019s Disease. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci9040073","journal-title":"Brain Sci"},{"key":"13429_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2020.173060","volume":"199","author":"T Pingale","year":"2020","unstructured":"Pingale T, Gupta GL (2020) Classic and evolving animal models in Parkinson\u2019s disease. Pharmacol Biochem Behav 199:173060. https:\/\/doi.org\/10.1016\/j.pbb.2020.173060","journal-title":"Pharmacol Biochem Behav"},{"key":"13429_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/JPD-171258","volume":"8","author":"JF Cooper","year":"2018","unstructured":"Cooper JF, Van Raamsdonk JM (2018) Modeling Parkinson\u2019s disease in C. elegans. J Parkinsons Dis 8:17\u201332. https:\/\/doi.org\/10.3233\/JPD-171258","journal-title":"J Parkinsons Dis"},{"key":"13429_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113893","author":"G Di Rosa","year":"2020","unstructured":"Di Rosa G et al (2020) Healthspan enhancement by olive polyphenols in C. elegans wild type and Parkinson\u2019s models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21113893","journal-title":"Int J Mol Sci"},{"key":"13429_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10565-018-09449-1","volume":"35","author":"B Vijayan","year":"2019","unstructured":"Vijayan B, Raj V, Nandakumar S, Kishore A, Thekkuveettil A (2019) Spermine protects alpha-synuclein expressing dopaminergic neurons from manganese-induced degeneration. Cell Biol Toxicol 35:147\u2013159. https:\/\/doi.org\/10.1007\/s10565-018-09449-1","journal-title":"Cell Biol Toxicol"},{"key":"13429_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25129","volume":"38","author":"Q Liang","year":"2024","unstructured":"Liang Q, Zhao G (2024) The effect of glna loss on the physiological and pathological phenotype of Parkinson\u2019s disease C. elegans. J Clin Lab Anal 38:e25129. https:\/\/doi.org\/10.1002\/jcla.25129","journal-title":"J Clin Lab Anal"},{"key":"13429_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/toxsci\/kfae066","volume":"200","author":"MR Ferreyra","year":"2024","unstructured":"Ferreyra MR et al (2024) Ferrostatin-1 mitigates cellular damage in a ferroptosis-like environment in Caenorhabditis elegans. Toxicol Sci 200:357\u2013368. https:\/\/doi.org\/10.1093\/toxsci\/kfae066","journal-title":"Toxicol Sci"},{"key":"13429_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJ (2017) The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener 12:10. https:\/\/doi.org\/10.1186\/s13024-017-0149-0","journal-title":"Mol Neurodegener"},{"key":"13429_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.151074","volume":"742","author":"Y Kato","year":"2025","unstructured":"Kato Y et al (2025) Cytoprotective effect of melatonin against MPP(+) toxicity in SH-SY5Y cells: role sharing of two types of antioxidative activities of melatonin. Biochem Biophys Res Commun 742:151074. https:\/\/doi.org\/10.1016\/j.bbrc.2024.151074","journal-title":"Biochem Biophys Res Commun"},{"key":"13429_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117172","volume":"494","author":"A Chakkittukandiyil","year":"2025","unstructured":"Chakkittukandiyil A et al (2025) Synthesis and evaluation of novel ethyl ferulate derivatives as potent Keap1 inhibitors to activate the Nrf2\/ARE pathway in Parkinson\u2019s disease. Toxicol Appl Pharmacol 494:117172. https:\/\/doi.org\/10.1016\/j.taap.2024.117172","journal-title":"Toxicol Appl Pharmacol"},{"key":"13429_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167553","volume":"1871","author":"Y Liu","year":"2025","unstructured":"Liu Y et al (2025) TMEM106B knockdown exhibits a neuroprotective effect in Parkinson\u2019s disease models via regulating autophagy-lysosome pathway. Biochimica et Biophysica Acta (BBA) 1871:167553. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167553","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"13429_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.214065","volume":"166","author":"JT Yang","year":"2025","unstructured":"Yang JT, Kuo YC, Lee KC, De S, Chen YY (2025) Resveratrol and ceftriaxone encapsulated in hybrid nanoparticles to prevent dopaminergic neurons from degeneration for Parkinson\u2019s disease treatment. Biomater Adv 166:214065. https:\/\/doi.org\/10.1016\/j.bioadv.2024.214065","journal-title":"Biomater Adv"},{"key":"13429_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8:73. https:\/\/doi.org\/10.1038\/s41392-023-01353-3","journal-title":"Signal Transduct Target Ther"},{"key":"13429_CR55","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3233\/JPD-179006","volume":"7","author":"JW Langston","year":"2017","unstructured":"Langston JW (2017) The MPTP story. J Parkinsons Dis 7:S11\u2013S19. https:\/\/doi.org\/10.3233\/JPD-179006","journal-title":"J Parkinsons Dis"},{"key":"13429_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough E, Barrett T (2016) The gene expression omnibus database. Methods Mol Biol 1418:93\u2013110. https:\/\/doi.org\/10.1007\/978-1-4939-3578-9_5","journal-title":"Methods Mol Biol"},{"key":"13429_CR57","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC et al (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5:R80. https:\/\/doi.org\/10.1186\/gb-2004-5-10-r80","journal-title":"Genome Biol"},{"key":"13429_CR58","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS (2007) GEOquery: a bridge between the gene expression omnibus (GEO) and bioconductor. Bioinformatics 23:1846\u20131847. https:\/\/doi.org\/10.1093\/bioinformatics\/btm254","journal-title":"Bioinformatics"},{"key":"13429_CR59","doi-asserted-by":"publisher","DOI":"10.2202\/1544-6115.1027","author":"GK Smyth","year":"2004","unstructured":"Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. https:\/\/doi.org\/10.2202\/1544-6115.1027","journal-title":"Stat Appl Genet Mol Biol"},{"key":"13429_CR60","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303","journal-title":"Genome Res"},{"key":"13429_CR61","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr et al (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3","journal-title":"Genome Biol"},{"key":"13429_CR62","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24956.2","author":"L Kolberg","year":"2020","unstructured":"Kolberg L, Raudvere U, Kuzmin I, Vilo J, Peterson H (2020) gprofiler2 \u2013 an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.24956.2","journal-title":"F1000Res"},{"key":"13429_CR63","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon JA et al (2022) JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res 50:D165\u2013D173. https:\/\/doi.org\/10.1093\/nar\/gkab1113","journal-title":"Nucleic Acids Res"},{"key":"13429_CR64","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou G et al (2019) NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res 47:W234\u2013W241. https:\/\/doi.org\/10.1093\/nar\/gkz240","journal-title":"Nucleic Acids Res"},{"key":"13429_CR65","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pinero","year":"2017","unstructured":"Pinero J et al (2017) DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res 45:D833\u2013D839. https:\/\/doi.org\/10.1093\/nar\/gkw943","journal-title":"Nucleic Acids Res"},{"key":"13429_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.679568","volume":"15","author":"B Li","year":"2021","unstructured":"Li B et al (2021) Gene4pd: a comprehensive genetic database of Parkinson\u2019s disease. Front Neurosci 15:679568. https:\/\/doi.org\/10.3389\/fnins.2021.679568","journal-title":"Front Neurosci"},{"key":"13429_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.31083\/j.jin2201020","volume":"22","author":"OC Ioghen","year":"2023","unstructured":"Ioghen OC, Ceafalan LC, Popescu BO (2023) SH-SY5Y cell line in vitro models for Parkinson disease research-old practice for new trends. J Integr Neurosci 22:20. https:\/\/doi.org\/10.31083\/j.jin2201020","journal-title":"J Integr Neurosci"},{"key":"13429_CR68","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12896-024-00918-6","volume":"24","author":"HAT Nguyen","year":"2024","unstructured":"Nguyen HAT et al (2024) Antioxidant, neuroprotective, and neuroblastoma cells (SH-SY5Y) differentiation effects of melanins and arginine-modified melanins from Daedaleopsis tricolor and Fomes fomentarius. BMC Biotechnol 24:89. https:\/\/doi.org\/10.1186\/s12896-024-00918-6","journal-title":"BMC Biotechnol"},{"key":"13429_CR69","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","volume":"77","author":"S Brenner","year":"1974","unstructured":"Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77:71\u201394. https:\/\/doi.org\/10.1093\/genetics\/77.1.71","journal-title":"Genetics"},{"key":"13429_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature01278","volume":"421","author":"RS Kamath","year":"2003","unstructured":"Kamath RS et al (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:231\u2013237. https:\/\/doi.org\/10.1038\/nature01278","journal-title":"Nature"},{"key":"13429_CR71","doi-asserted-by":"publisher","first-page":"13713","DOI":"10.1038\/s41598-024-64045-0","volume":"14","author":"Z Zhang","year":"2024","unstructured":"Zhang Z et al (2024) Jujubae fructus extract prolongs lifespan and improves stress tolerance in Caenorhabditis elegans dependent on DAF-16\/SOD-3. Sci Rep 14:13713. https:\/\/doi.org\/10.1038\/s41598-024-64045-0","journal-title":"Sci Rep"},{"key":"13429_CR72","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2144\/000112517","volume":"43","author":"TJ Collins","year":"2007","unstructured":"Collins TJ (2007) Imagej for microscopy. Biotechniques 43:25\u201330. https:\/\/doi.org\/10.2144\/000112517","journal-title":"Biotechniques"},{"key":"13429_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007608","volume":"14","author":"S Verma","year":"2018","unstructured":"Verma S, Jagtap U, Goyala A, Mukhopadhyay A (2018) A novel gene-diet pair modulates C. elegans aging. PLoS Genet 14:e1007608. https:\/\/doi.org\/10.1371\/journal.pgen.1007608","journal-title":"PLoS Genet"},{"key":"13429_CR74","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.4161\/epi.25865","volume":"8","author":"E Masliah","year":"2013","unstructured":"Masliah E, Dumaop W, Galasko D, Desplats P (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 8:1030\u20131038. https:\/\/doi.org\/10.4161\/epi.25865","journal-title":"Epigenetics"},{"key":"13429_CR75","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15592294.2019.1588682","volume":"14","author":"A Henderson-Smith","year":"2019","unstructured":"Henderson-Smith A et al (2019) DNA methylation changes associated with Parkinson\u2019s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood. Epigenetics 14:365\u2013382. https:\/\/doi.org\/10.1080\/15592294.2019.1588682","journal-title":"Epigenetics"},{"key":"13429_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149097","volume":"936","author":"ZC Yang","year":"2025","unstructured":"Yang ZC et al (2025) Identification and validation of biomarkers related to mitochondria during ex vivo lung perfusion for lung transplants based on machine learning algorithm. Gene 936:149097. https:\/\/doi.org\/10.1016\/j.gene.2024.149097","journal-title":"Gene"},{"key":"13429_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148974","volume":"933","author":"J Zhu","year":"2025","unstructured":"Zhu J et al (2025) Integration of bioinformatics and multi-layered experimental validation reveals novel functions of acetylation-related genes in intervertebral disc degeneration. Gene 933:148974. https:\/\/doi.org\/10.1016\/j.gene.2024.148974","journal-title":"Gene"},{"key":"13429_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148877","volume":"931","author":"L Huang","year":"2024","unstructured":"Huang L et al (2024) A nomoscore of four genes for predicting the rupture risk in abdominal aortic aneurysm patients with osteoarthritis. Gene 931:148877. https:\/\/doi.org\/10.1016\/j.gene.2024.148877","journal-title":"Gene"},{"key":"13429_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148840","volume":"930","author":"J Huang","year":"2024","unstructured":"Huang J et al (2024) Identification of key mitochondria-related genes and their potential crosstalk role with immune pattern in Idiopathic pulmonary fibrosis. Gene 930:148840. https:\/\/doi.org\/10.1016\/j.gene.2024.148840","journal-title":"Gene"},{"key":"13429_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148711","volume":"927","author":"J Ke","year":"2024","unstructured":"Ke J et al (2024) Integrated bioinformatic analysis and experimental validation for exploring the key immune checkpoint of COPD. Gene 927:148711. https:\/\/doi.org\/10.1016\/j.gene.2024.148711","journal-title":"Gene"},{"key":"13429_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148634","volume":"927","author":"R Zhou","year":"2024","unstructured":"Zhou R et al (2024) Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer. Gene 927:148634. https:\/\/doi.org\/10.1016\/j.gene.2024.148634","journal-title":"Gene"},{"key":"13429_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148410","volume":"915","author":"L Zhou","year":"2024","unstructured":"Zhou L et al (2024) Identification and preliminary validation of differently expressed genes as candidate biomarkers associated with atherosclerosis. Gene 915:148410. https:\/\/doi.org\/10.1016\/j.gene.2024.148410","journal-title":"Gene"},{"key":"13429_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148381","volume":"914","author":"P Cui","year":"2024","unstructured":"Cui P et al (2024) Identification and validation of ferroptosis-related lncRNA signature in intervertebral disc degeneration. Gene 914:148381. https:\/\/doi.org\/10.1016\/j.gene.2024.148381","journal-title":"Gene"},{"key":"13429_CR84","doi-asserted-by":"publisher","first-page":"1659947","DOI":"10.3389\/fimmu.2025.1659947","volume":"16","author":"L Muller","year":"2025","unstructured":"Muller L, Di Benedetto S, Muller V (2025) The dual nature of neuroinflammation in networked brain. Front Immunol 16:1659947. https:\/\/doi.org\/10.3389\/fimmu.2025.1659947","journal-title":"Front Immunol"},{"key":"13429_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.848476","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Zhou H, Li S (2022) BTN3A2 expression is connected with favorable prognosis and high infiltrating immune in lung adenocarcinoma. Front Genet 13:848476. https:\/\/doi.org\/10.3389\/fgene.2022.848476","journal-title":"Front Genet"},{"key":"13429_CR86","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/brain\/awad322","volume":"147","author":"A Kouli","year":"2024","unstructured":"Kouli A et al (2024) Neuroinflammation is linked to dementia risk in Parkinson\u2019s disease. Brain 147:923\u2013935. https:\/\/doi.org\/10.1093\/brain\/awad322","journal-title":"Brain"},{"key":"13429_CR87","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/icb.2010.57","volume":"88","author":"N Rahman","year":"2010","unstructured":"Rahman N, Stewart G, Jones G (2010) A role for the atopy-associated gene PHF11 in T-cell activation and viability. Immunol Cell Biol 88:817\u2013824. https:\/\/doi.org\/10.1038\/icb.2010.57","journal-title":"Immunol Cell Biol"},{"key":"13429_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105797","volume":"114","author":"HD Nguyen","year":"2023","unstructured":"Nguyen HD et al (2023) Upregulation of immunoproteasome PSMB8 is associated with Parkinson\u2019s disease. Parkinsonism Relat Disord 114:105797. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105797","journal-title":"Parkinsonism Relat Disord"},{"key":"13429_CR89","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00401-020-02177-z","volume":"141","author":"S Fanning","year":"2021","unstructured":"Fanning S, Selkoe D, Dettmer U (2021) Vesicle trafficking and lipid metabolism in synucleinopathy. Acta Neuropathol 141:491\u2013510. https:\/\/doi.org\/10.1007\/s00401-020-02177-z","journal-title":"Acta Neuropathol"},{"key":"13429_CR90","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/imcb.12503","volume":"99","author":"LC Dominguez Cadena","year":"2021","unstructured":"Dominguez Cadena LC et al (2021) Rab6b localizes to the Golgi complex in murine macrophages and promotes tumor necrosis factor release in response to mycobacterial infection. Immunol Cell Biol 99:1067\u20131076. https:\/\/doi.org\/10.1111\/imcb.12503","journal-title":"Immunol Cell Biol"},{"key":"13429_CR91","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1523\/JNEUROSCI.5221-12.2013","volume":"33","author":"LF Gumy","year":"2013","unstructured":"Gumy LF et al (2013) The kinesin-2 family member KIF3C regulates microtubule dynamics and is required for axon growth and regeneration. J Neurosci 33:11329\u201311345. https:\/\/doi.org\/10.1523\/JNEUROSCI.5221-12.2013","journal-title":"J Neurosci"},{"key":"13429_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115352","volume":"44","author":"N Ageta-Ishihara","year":"2025","unstructured":"Ageta-Ishihara N et al (2025) Septin 3 regulates memory and L-LTP-dependent extension of endoplasmic reticulum into spines. Cell Rep 44:115352. https:\/\/doi.org\/10.1016\/j.celrep.2025.115352","journal-title":"Cell Rep"},{"key":"13429_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01576-w","author":"WL Wu","year":"2025","unstructured":"Wu WL, Gong XX, Qin ZH, Wang Y (2025) Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update. Acta Pharmacol Sin. https:\/\/doi.org\/10.1038\/s41401-025-01576-w","journal-title":"Acta Pharmacol Sin"},{"key":"13429_CR94","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41392-023-01427-2","volume":"8","author":"TS Wong","year":"2023","unstructured":"Wong TS et al (2023) G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduct Target Ther 8:177. https:\/\/doi.org\/10.1038\/s41392-023-01427-2","journal-title":"Signal Transduct Target Ther"},{"key":"13429_CR95","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0076-6879(04)90009-2","volume":"390","author":"O Saitoh","year":"2004","unstructured":"Saitoh O, Yoshihiro K (2004) Biochemical and electrophysiological analyses of RGS8 function. Methods Enzymol 390:129\u2013148. https:\/\/doi.org\/10.1016\/S0076-6879(04)90009-2","journal-title":"Methods Enzymol"},{"key":"13429_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.971298","volume":"13","author":"SL Schaffner","year":"2022","unstructured":"Schaffner SL, Kobor MS (2022) DNA methylation as a mediator of genetic and environmental influences on Parkinson\u2019s disease susceptibility: impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome. Front Genet 13:971298. https:\/\/doi.org\/10.3389\/fgene.2022.971298","journal-title":"Front Genet"},{"key":"13429_CR97","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jgg.2016.05.002","volume":"43","author":"L Zhang","year":"2016","unstructured":"Zhang L et al (2016) Targeted methylation sequencing reveals dysregulated Wnt signaling in Parkinson disease. J Genet Genomics 43:587\u2013592. https:\/\/doi.org\/10.1016\/j.jgg.2016.05.002","journal-title":"J Genet Genomics"},{"key":"13429_CR98","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1242\/bio.20135009","volume":"2","author":"JA Siegenthaler","year":"2013","unstructured":"Siegenthaler JA et al (2013) Foxc1 is required by pericytes during fetal brain angiogenesis. Biol Open 2:647\u2013659. https:\/\/doi.org\/10.1242\/bio.20135009","journal-title":"Biol Open"},{"key":"13429_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2018.11.023","volume":"216","author":"S Xia","year":"2019","unstructured":"Xia S et al (2019) Overexpression of forkhead box C1 attenuates oxidative stress, inflammation and apoptosis in chronic obstructive pulmonary disease. Life Sci 216:75\u201384. https:\/\/doi.org\/10.1016\/j.lfs.2018.11.023","journal-title":"Life Sci"},{"key":"13429_CR100","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13073-023-01172-9","volume":"15","author":"CC Sun","year":"2023","unstructured":"Sun CC et al (2023) FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1alpha pathway. Genome Med 15:23. https:\/\/doi.org\/10.1186\/s13073-023-01172-9","journal-title":"Genome Med"},{"key":"13429_CR101","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2017.16","volume":"22","author":"AH Ashok","year":"2017","unstructured":"Ashok AH et al (2017) The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol Psychiatry 22:666\u2013679. https:\/\/doi.org\/10.1038\/mp.2017.16","journal-title":"Mol Psychiatry"},{"key":"13429_CR102","first-page":"66","volume":"35","author":"R Geelhand de Merxem","year":"2023","unstructured":"Geelhand de Merxem R, Launay S, Hanak C (2023) Association between bipolar disorder and Parkinson\u2019s disease. Psychiatr Danub 35:66\u201371","journal-title":"Psychiatr Danub"},{"key":"13429_CR103","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3233\/JPD-202521","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y et al (2021) Non-genetic risk factors for Parkinson\u2019s disease: an overview of 46 systematic reviews. J Parkinsons Dis 11:919\u2013935. https:\/\/doi.org\/10.3233\/JPD-202521","journal-title":"J Parkinsons Dis"},{"key":"13429_CR104","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.b.30780","volume":"150B","author":"B Kerner","year":"2009","unstructured":"Kerner B et al (2009) Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 150B:24\u201332. https:\/\/doi.org\/10.1002\/ajmg.b.30780","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"13429_CR105","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12920-016-0164-y","volume":"9","author":"A Dumitriu","year":"2016","unstructured":"Dumitriu A et al (2016) Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease. BMC Med Genomics 9:5. https:\/\/doi.org\/10.1186\/s12920-016-0164-y","journal-title":"BMC Med Genomics"},{"key":"13429_CR106","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/dvdy.21447","volume":"237","author":"V Hoppmann","year":"2008","unstructured":"Hoppmann V, Wu JJ, Soviknes AM, Helvik JV, Becker TS (2008) Expression of the eight AMPA receptor subunit genes in the developing central nervous system and sensory organs of zebrafish. Dev Dyn 237:788\u2013799. https:\/\/doi.org\/10.1002\/dvdy.21447","journal-title":"Dev Dyn"},{"key":"13429_CR107","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fneur.2019.01143","volume":"10","author":"E Palasz","year":"2019","unstructured":"Palasz E et al (2019) Exercise-induced neuroprotection and recovery of motor function in animal models of Parkinson\u2019s disease. Front Neurol 10:1143. https:\/\/doi.org\/10.3389\/fneur.2019.01143","journal-title":"Front Neurol"},{"key":"13429_CR108","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41531-023-00620-y","volume":"10","author":"JR Patterson","year":"2024","unstructured":"Patterson JR et al (2024) Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils. NPJ Parkinsons Dis 10:7. https:\/\/doi.org\/10.1038\/s41531-023-00620-y","journal-title":"NPJ Parkinsons Dis"},{"key":"13429_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003067","volume":"8","author":"JL Wagnon","year":"2012","unstructured":"Wagnon JL et al (2012) CELF4 regulates translation and local abundance of a vast set of mRNAs, including genes associated with regulation of synaptic function. PLoS Genet 8:e1003067. https:\/\/doi.org\/10.1371\/journal.pgen.1003067","journal-title":"PLoS Genet"},{"key":"13429_CR110","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41431-018-0321-1","volume":"27","author":"C Scuderi","year":"2019","unstructured":"Scuderi C et al (2019) Biallelic intragenic duplication in ADGRB3 (BAI3) gene associated with intellectual disability, cerebellar atrophy, and behavioral disorder. Eur J Hum Genet 27:594\u2013602. https:\/\/doi.org\/10.1038\/s41431-018-0321-1","journal-title":"Eur J Hum Genet"},{"key":"13429_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113424","author":"AS Kone","year":"2022","unstructured":"Kone AS, Ait Ssi S, Sahraoui S, Badou A (2022) BTN3A: a promising immune checkpoint for cancer prognosis and treatment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113424","journal-title":"Int J Mol Sci"},{"key":"13429_CR112","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13041-020-00666-6","volume":"13","author":"T Nakagawa","year":"2020","unstructured":"Nakagawa T et al (2020) Expression of the pacemaker channel HCN4 in excitatory interneurons in the dorsal horn of the murine spinal cord. Mol Brain 13:127. https:\/\/doi.org\/10.1186\/s13041-020-00666-6","journal-title":"Mol Brain"},{"key":"13429_CR113","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.76497","author":"S Ray","year":"2022","unstructured":"Ray S et al (2022) Functional requirements for a Samd14-capping protein complex in stress erythropoiesis. Elife. https:\/\/doi.org\/10.7554\/eLife.76497","journal-title":"Elife"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13429-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13429-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13429-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:02:49Z","timestamp":1773784969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13429-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":113,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["13429"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13429-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not require approval from an institutional ethics committee, as it did not involve human participants, animal subjects, or sensitive data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"135"}}